Cargando…
Minnelide: A Novel Therapeutic That Promotes Apoptosis in Non-Small Cell Lung Carcinoma In Vivo
BACKGROUND: Minnelide, a pro-drug of triptolide, has recently emerged as a potent anticancer agent. The precise mechanisms of its cytotoxic effects remain unclear. METHODS: Cell viability was studied using CCK8 assay. Cell proliferation was measured real-time on cultured cells using Electric Cell Su...
Autores principales: | Rousalova, Ilona, Banerjee, Sulagna, Sangwan, Veena, Evenson, Kristen, McCauley, Joel A., Kratzke, Robert, Vickers, Selwyn M., Saluja, Ashok, D’Cunha, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797124/ https://www.ncbi.nlm.nih.gov/pubmed/24143232 http://dx.doi.org/10.1371/journal.pone.0077411 |
Ejemplares similares
-
Triptolide and its prodrug minnelide suppress Hsp70 and inhibit in vivo growth in a xenograft model of mesothelioma
por: Jacobson, Blake A., et al.
Publicado: (2015) -
Minnelide effectively eliminates CD133(+) side population in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015) -
Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia
por: Giri, Bhuwan, et al.
Publicado: (2019) -
Correction to: Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia
por: Giri, Bhuwan, et al.
Publicado: (2019) -
Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer
por: Arora, Nivedita, et al.
Publicado: (2017)